Collaborateurs·trices
![Institut Sciences du Vivant : Expert en Ra&D, prestations de service et formation continue. Nos équipes interdisciplinaires collaborent avec l'industrie pour proposer des solutions innovantes et durables. 90 collaborateurs, infrastructures ultra-modernes, plus de 200 projets annuels en pharmaceutique, biopharmaceutique, environnement, biotechnologie, diagnostic, sciences alimentaires, chimie.](/media/image/21/xlarge_2_1/life-technolgies.jpg?4f669bb961c3e92f60b802b35d069e43)
Fonctions | Professeur·e HES ordinaire |
---|---|
Téléphone | |
gerrit.hagens@hevs.ch | |
Bureau | ENP 19.N305 |
Dr. Gerrit Hagens obtained his PhD in molecular biology from the University of Berne and soon after managed a research group at the University of Geneva. In 2000 he was hired by Serono International and became a member of Serono’s core team where he managed all strategic projects of the Neurology Business Unit. Most important projects included development of a new Rebif`clone to satisfy worldwide Rebif demand, and the clinical trial in the US which resulted in the marketing authorisation from the FDA. In 2004 Gerrit was appointed COO and President of ExcellGene, a company specialised in manufacturing process development of biologics, and in 2008 he became COO of RiboVax focussing on development of monoclonal antibodies. In 2008 he also co-founded NatiMab (R&D monoclonal antibodies) and in 2010 he joined BioXpress where he headed project management.
Since Janaury 2017 Gerrit Hagens is Professor at the University of Applied Sciences and Arts Western Switzerland (HES-SO // Valais - Wallis). Gerrit's interests include: